Tsumura & Co. (TYO:4540)

Japan · Delayed Price · Currency is JPY

3,889.00

+66.00 (1.73%)

Jul 14, 2026, 3:30 PM JST

9.49% (1Y)

Market Cap	289.91B +16.0%
Revenue (ttm)	192.62B +6.4%
Net Income	28.12B -13.3%
EPS	376.28 -11.9%
Shares Out	74.55M
PE Ratio	10.34
Forward PE	11.14
Dividend	158.00 (4.13%)
Ex-Dividend Date	Mar 30, 2026

Volume	430,500
Open	3,847.00
Previous Close	3,823.00
Day's Range	3,824.00 - 3,919.00
52-Week Range	3,418.00 - 4,403.00
Beta	0.07
Analysts	Hold
Price Target	4,400.00 (+13.14%)
Earnings Date	Aug 6, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1893

Employees 4,923

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4540

Full Company Profile

Financial Performance

In fiscal year 2026, Tsumura & Co.'s revenue was 192.62 billion, an increase of 6.36% compared to the previous year's 181.09 billion. Earnings were 28.12 billion, a decrease of -13.29%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 4540 stock is "Hold." The 12-month stock price target is ¥4,400, which is an increase of 13.14% from the latest price.

Price Target

¥4,400

(13.14% upside)

Analyst Consensus: Hold

Stock Forecasts